WVCTSI announces 4 fall funding opportunities

WVCTSI announces 4 fall funding opportunities

The West Virginia Clinical and Translational Science Institute (WVCTSI) has released requests for applications (RFA) for the Open Competition, Launch Pilot Grant, Small Grant, and Open Competition (WVCTSI and WVU Cancer Institute) funding opportunities.

The Open Competition RFA allows applicants to request up to $50,000 in funding which must be utilized over a 12 month period. This funding opportunity seeks to find innovative research that addresses healthcare needs in West Virginia. Examples include, but are not limited to, addiction and resultant emerging epidemics, cancer, cardiovascular disease, chronic lung disease, and neuroscience. 

The Launch Pilot Grant program focuses on accelerating the translation of intellectual property developed by WVCTSI researchers into realized inventions and patents. Applicants can request up to $50,000 in funding, which must be utilized over 9 months.

The Small Grants RFA is an open competition where applicants can request up to $5,000 in funding to address the health care needs of West Virginia. This funding must be utilized over 6 months.

WVCTSI and the WVU Cancer Institute have also partnered to offer an Open Grant Competition RFA for Cancer Research. This collaborative funding opportunity allows applicants to request up to $50,000 that must be utilized over 24 months. Applications must focus on cancer topics, including cancer clinical research, cancer prevention and early detection research, and/or laboratory based cancer research.

For information on Letter of Intent and full proposal deadlines for Fall 2018, visit the WVCTSI funding page.

Applications should follow all stated guidelines and must be submitted via the iLab platform. Detailed instructions on the application process can be found in each individual RFA. Questions about available funding opportunities should be directed to Camille Charlier (ccharlie@hsc.wvu.edu) or Meghan Reeves (mreeves1@hsc.wvu.edu).

WVCTSI will be hosting multiple information sessions for those interested in applying for any of the fall funding opportunities. Dates and locations for sessions can be found below, additional details will be released soon.

  • WVU Health Sciences Center- Room 201 of the Erma Byrd Biomedical Research Building
    • Tuesday, October 16, 9 to 10 a.m.

    • Wednesday, October 17, 4:30 to 5:30 p.m.

  • Marshall University: Thursday, October 25, 4 to 5 p.m.- Cabell Medical Center Orthopedic Classroom
  • Charleston Area Medical Center: Friday, October 26, 12 to 1 p.m.- CHERI Building Conference Room A&B

-WVCTSI-

im 9/26/18

 

CONTACT:

Camille Charlier, West Virginia Clinical and Translational Science Institute

304.293.4275 wvctsi.org 

  • WVU, partners announce regional hub to train entrepreneurs, commercialize healthcare technology

    WVU, partners announce regional hub to train entrepreneurs, commercialize healthcare technology

    Hoping to speed up the move from idea to application, West Virginia University and 23 other regional institutions have come together to create a “virtual hub” that will ultimately help speed the commercialization of groundbreaking university research. 

    Read More

  • Community-based research town hall

    WVCTSI and the WVU Mountaineer Health Initiative are co-sponsoring a town hall meeting to highlight research taking place across the state. “Conversation and Collaboration: WVU Community-Based Researchers and Outreach Staff Making a Difference,” offers attendees the chance to learn about the range of community engaged research and outreach across the state, meet colleagues engaged in similar work, identify common issues, and ascertain better ways to support each other in the field.

    Read More

  • Du Publishes Two Studies That Describe an Improved Approach to Bone Marrow Transplant

    Du Publishes Two Studies That Describe an Improved Approach to Bone Marrow Transplant

    WVU cancer researcher Wei Du, MD, PhD, teamed up with researchers from Cincinnati Children’s Hospital Medical Center to focus on improving outcomes and reducing side effects of traditional stem cell transplant. Their work was recently published in Leukemia, one of the top journals in hematology.

    Read More